Atsuo Takashima Selected Research

Acneiform Eruptions

5/2022	Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part).
7/2021	Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induced by cetuximab and panitumumab: A multicenter, phase II trial.
1/2019	Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsuo Takashima Research Topics

Disease

43	Neoplasms (Cancer) 10/2022 - 01/2008
40	Stomach Neoplasms (Stomach Cancer) 05/2021 - 08/2008
38	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 01/2009
21	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2010
10	Disease Progression 01/2021 - 05/2011
9	Adenocarcinoma 01/2022 - 01/2008
9	Esophageal Squamous Cell Carcinoma 06/2020 - 12/2014
6	Carcinoma (Carcinomatosis) 02/2021 - 04/2015
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2020 - 10/2009
4	Hemorrhage 04/2021 - 08/2009
4	Esophageal Neoplasms (Esophageal Cancer) 06/2020 - 12/2014
3	Acneiform Eruptions 05/2022 - 01/2019
3	Residual Neoplasm 02/2022 - 02/2009
3	Ascites 12/2020 - 01/2012
3	Neuroendocrine Carcinoma 01/2020 - 09/2014
3	Anorexia 01/2020 - 08/2010
3	Diarrhea 10/2019 - 08/2010
3	Neutropenia 01/2017 - 10/2013
2	Head and Neck Neoplasms (Head and Neck Cancer) 07/2021 - 03/2019
2	Malignant Mesothelioma 03/2021 - 12/2019
2	Mesothelioma 03/2021 - 12/2019
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2018
2	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2020
2	Wounds and Injuries (Trauma) 10/2020 - 04/2015
2	Hypertension (High Blood Pressure) 01/2020 - 12/2012
2	Lung Neoplasms (Lung Cancer) 10/2019 - 06/2009
2	Mucositis 10/2019 - 09/2016
2	Rectal Neoplasms (Rectal Cancer) 07/2019 - 05/2017
2	Febrile Neutropenia 01/2017 - 08/2010
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016 - 09/2014
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2013 - 12/2010
2	Nausea 08/2010 - 07/2009
1	Inflammation (Inflammations) 11/2021
1	Bacterial Infections (Bacterial Infection) 07/2021
1	Keloid 05/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2021
1	Thrombosis (Thrombus) 04/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 04/2021

Drug/Important Bio-Agent (IBA)

17	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2008
15	Irinotecan (Camptosar)FDA LinkGeneric 04/2021 - 01/2008
15	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 08/2008
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 12/2012
10	Bevacizumab (Avastin)FDA Link 01/2022 - 05/2012
8	ErbB Receptors (EGF Receptor)IBA 05/2022 - 01/2009
8	Biomarkers (Surrogate Marker)IBA 02/2022 - 05/2012
8	PlatinumIBA 01/2022 - 12/2014
8	trifluridine tipiracil drug combinationIBA 01/2022 - 01/2018
8	regorafenibIBA 01/2022 - 01/2018
7	Panitumumab (Vectibix)FDA Link 05/2022 - 07/2016
6	Paclitaxel (Taxol)FDA LinkGeneric 04/2020 - 08/2008
5	Cetuximab (Erbitux)FDA Link 05/2022 - 07/2016
5	NivolumabIBA 01/2022 - 01/2019
4	RamucirumabIBA 04/2020 - 07/2017
4	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2017
4	Docetaxel (Taxotere)FDA Link 03/2019 - 12/2014
4	Leucovorin (Folinic Acid)FDA Link 05/2017 - 08/2008
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
3	S-1 plus cisplatinIBA 01/2022 - 12/2013
3	Monoclonal AntibodiesIBA 01/2022 - 01/2018
3	C-Reactive ProteinIBA 11/2021 - 07/2010
3	Taxoids (Taxanes)IBA 03/2021 - 12/2014
3	Trastuzumab (Herceptin)FDA Link 11/2019 - 10/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022 - 07/2021
2	EnzymesIBA 01/2022 - 01/2019
2	andecaliximabIBA 01/2022 - 01/2022
2	Formaldehyde (Formol)FDA Link 04/2021 - 04/2014
2	ParaffinIBA 04/2021 - 04/2014
2	Pemetrexed (MTA)FDA Link 03/2021 - 12/2019
2	Capecitabine (Xeloda)FDA Link 01/2021 - 10/2014
2	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2019
2	SolventsIBA 01/2020 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 02/2009
2	Antineoplastic Agents (Antineoplastics)IBA 08/2019 - 02/2011
2	AntibodiesIBA 01/2019 - 01/2016
2	Serum AlbuminIBA 12/2018 - 07/2010
2	taxaneIBA 09/2017 - 12/2014
2	LigandsIBA 08/2016 - 05/2015
2	Indicators and Reagents (Reagents)IBA 01/2016 - 04/2014
2	Methotrexate (Mexate)FDA LinkGeneric 10/2013 - 02/2010
2	Gemcitabine FDA Link 09/2013 - 12/2010
1	Notch ReceptorsIBA 10/2022
1	Minocycline (Cyclops)FDA LinkGeneric 05/2022
1	Sunscreening Agents (Sunscreens)IBA 05/2022
1	Tetracycline (Achromycin)FDA LinkGeneric 05/2022
1	Messenger RNA (mRNA)IBA 02/2022
1	Therapeutic UsesIBA 02/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	Benzoyl Peroxide FDA LinkGeneric 07/2021
1	CollagenIBA 05/2021

Therapy/Procedure

60	Drug Therapy (Chemotherapy) 10/2022 - 01/2008
25	Therapeutics 05/2022 - 08/2008
9	Chemoradiotherapy 04/2020 - 10/2009
5	Gastrectomy 05/2021 - 02/2009
5	Radiotherapy 06/2020 - 08/2009
4	Adjuvant Chemotherapy 05/2021 - 01/2017
4	Combination Drug Therapy (Combination Chemotherapy) 05/2018 - 01/2008
2	Intravenous Infusions 01/2022 - 02/2011
2	Immunotherapy 01/2021 - 01/2019
2	Esophagectomy 08/2018 - 01/2017